Table 1

Baseline Demographic and Clinical Data

    Treatment

    Placebo

    P value


n (female/male)

35 (22/13)

40 (28/12)

0.513

Age (yr)

44.5 ± 2.2

45.3 ± 2.0

0.796

Blood pressure (systolic/diastolic, mmHg)

121/69 ± 2.2/1.4

121.6/67.1 ± 1.9/1.5

0.868/0.760

Weight (kg)

81.8 ± 2.8

79.6 ± 2.9

0.598

Total Cholesterol (mmol/L)

6.2 ± 0.1

6.2 ± 0.1

0.976

Triglyceride (mmol/L)*

1.9 ± 0.1

1.9 ± 0.2

0.989

HDL cholesterol (mmol/L)

1.4 ± 0.06

1.3 ± 0.05

0.806

LDL cholesterol (mmol/L)**

4.1 ± 0.1

4.2 ± 0.1

0.651

Cholesterol/HDL ratio

4.8 ± 0.2

4.8 ± 0.2

0.981

C-Reactive protein (mg/dL)

0.35 ± 0.08

0.38 ± .06

0.817

Homocysteine (μmol/L)

8.0 ± 0.3

7.9 ± 0.3

0.861

Insulin (pmol/L)

56.2 ± 4.2

68.1 ± 9.0

0.273

Glucose (mmol/L)

5.4 ± 0.3

5.3 ± 0.1

0.840


Data are means ± SEM.

* Excludes one subject in the Placebo group with fasting triglycerides > 400 mg/dL.

** Excludes two subjects in the Placebo group with fasting triglycerides > 400 mg/dL

Queenan et al. Nutrition Journal 2007 6:6   doi:10.1186/1475-2891-6-6

Open Data